Lyell Immunopharma shares owned by Baillie Gifford & Co
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Baillie Gifford & Co
from 13F filings
Historical chart of Baillie Gifford & Co investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Baillie Gifford & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Baillie Gifford & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.3M | 691k | 1.94 |
| 2023-09-30 | $1.1M | 733k | 1.47 |
| 2023-06-30 | $2.4M | 761k | 3.18 |
| 2023-03-31 | $1.8M | 761k | 2.36 |
| 2022-12-31 | $2.6M | 761k | 3.47 |
| 2022-09-30 | $5.5M | 755k | 7.33 |
| 2022-06-30 | $4.6M | 708k | 6.52 |
| 2022-03-31 | $4.0M | 785k | 5.05 |
| 2021-12-31 | $5.6M | 723k | 7.74 |
| 2021-09-30 | $6.3M | 428k | 14.81 |
| 2021-06-30 | $4.2M | 259k | 16.25 |